Back to Stakeholders

Digital ketamine treatment platform offering app-enabled preparation, guided sessions, and integration support for mental health care.

Clinical Care Delivery Snapshot

Virtual & Hybrid Care Providers

Provider Model

Virtual Care Platform

Organization Status

Unknown

Psychedelic Services

Unknown

Service Coverage

1 country

Service Profile

Care Settings

Telehealth / Virtual

Payer Models

Unknown

Service Coverage Countries

United States

Non-Psychedelic Service Mix

Unknown

Visit Provider

Care Delivery Notes

Seeded from user-provided care-delivery.xlsx list. Contacts: Juan Pablo Cappello (CEO & Co-Founder) Contact emails: welcome@nue.life

Practitioner-Led Care Snapshot

Facilitation Provider Organizations

Organization Model

Telehealth-Enabled Practitioner Network

Organization Status

Active

Psychedelic Services

Active Psychedelic-Related Offering

Service Coverage

National

Care Profile

Care Modalities

Preparation & Integration Sessions

Access Pathways

Unknown / Unclear
Visit Provider

Technology, Data, & Software Snapshot

Digital Therapeutics

Platform Model

Digital Therapeutics Product

Deployment

SaaS Application

Geography

National

Coverage

1 country

Customer Types

Patient / Consumer PopulationsClinical Providers / Networks

Capability Focus Areas

Digital Care PathwaysProtocol / Decision Support

Data Modalities

Patient-Reported OutcomesBehavioral / Survey Data

Technology Notes

Nue Life presents a platformized ketamine treatment program with digital patient support and structured treatment workflows.

Verification

Verified

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement Status

Active

Last Verified

Apr 9, 2026

Primary Platform Link

Quick Facts

HQ
United States
Website
Visit